Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
Radiologic Clinics of North America|July 16, 2002
Breast imaging reporting and data system (BI-RADS)Laura Liberman, Jennifer H MenellGynecologic Oncology|June 12, 2003
The use of MRI in the diagnosis and management of a bulky cervical carcinomaJennifer H Menell, Dennis S Chi, Lucy E Hann, et al.The Breast Journal|November 22, 2005
Determination of the presence and extent of pure ductal carcinoma in situ by mammography and magnetic resonance imagingJennifer H Menell, Elizabeth A Morris, D David Dershaw, et al.AJR. American Journal of Roentgenology|August 20, 2002
To excise or to sample the mammographic target: what is the goal of stereotactic 11-gauge vacuum-assisted breast biopsy?Laura Liberman, Jennifer B Kaplan, Elizabeth A Morris, et al.Radiology|May 30, 2003
Breast lesions detected with MR imaging: utility and histopathologic importance of identification with USLinda R LaTrenta, Jennifer H Menell, Elizabeth A Morris, et al.AJR. American Journal of Roentgenology|January 24, 2003
MR imaging findings in the contralateral breast of women with recently diagnosed breast cancerLaura Liberman, Elizabeth A Morris, Cathleen M Kim, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 2002
Temozolomide plus thalidomide in patients with advanced melanoma: results of a dose-finding trialWen-Jen Hwu, Susan E Krown, Katherine S Panageas, et al.AJR. American Journal of Roentgenology|June 22, 2002
Breast lesions detected on MR imaging: features and positive predictive valueLaura Liberman, Elizabeth A Morris, Melissa Joo-Young Lee, et al.Cancer|April 28, 2006
Phase II study of temozolomide plus pegylated interferon-alpha-2b for metastatic melanomaWen-Jen Hwu, Katherine S Panageas, Jennifer H Menell, et al.Cancer|April 30, 2005
Temozolomide plus thalidomide in patients with brain metastases from melanoma: a phase II studyWen-Jen Hwu, Eric Lis, Jennifer H Menell, et al.Pageof 2